Learning Objectives

• Describe the effects of hemophilia with and without inhibitors on clinical, economic, and humanistic outcomes
• Employ a collaborative and comprehensive care model, including partnering with HTCs, to optimize clinical and economic outcomes for health plan patients with hemophilia
• Recommend hemophilia management policies and protocols to optimize patient outcomes in a managed care and/or specialty pharmacy setting
• Provide accurate and appropriate counsel as part of the treatment team
• Provide appropriate care and counsel for patients and their families

Celynda G. Tadlock, PharmD, MBA Vice President, Pharmacy Business Development Aetna